|

|

Area Editoriale


26/10/2020

Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis

Gastroenterology, June 2020

09/04/2020

Efficacia nella vita reale di Tofacitinib in pazienti con colite ulcerosa refrattaria

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis Lair-Mehiri L, Digestive and Liver Disease, 2020-03-01,52 (3) 268-273

16/01/2020

Vedolizumab versus Adalimumab nel trattamento della colite ulcerosa moderato-severa – studio VARSITY

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis Sands BE et al. N.Engl J Med 2019;381:1215-26